Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway M Kawada, S Yamagoe, Y Murakami, K Suzuki, S Mizuno, Y Uehara Oncogene 15 (6), 629-637, 1997 | 268 | 1997 |
Tumor-derived exosomes in the regulation of macrophage polarization MS Baig, A Roy, S Rajpoot, D Liu, R Savai, S Banerjee, M Kawada, ... Inflammation Research 69, 435-451, 2020 | 200 | 2020 |
Potential anticancer activity of auranofin T Onodera, I Momose, M Kawada Chemical and Pharmaceutical Bulletin 67 (3), 186-191, 2019 | 125 | 2019 |
Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer M Kawada, H Inoue, T Masuda, D Ikeda Cancer research 66 (8), 4419-4425, 2006 | 109 | 2006 |
Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell‐induced angiogenesis K Minamiguchi, H Kumagai, T Masuda, M Kawada, M Ishizuka, ... International journal of cancer 93 (3), 307-316, 2001 | 87 | 2001 |
A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis M Arakawa, T Someno, M Kawada, D Ikeda The Journal of antibiotics 61 (7), 442-448, 2008 | 76 | 2008 |
Leucinostatin A inhibits prostate cancer growth through reduction of insulin‐like growth factor‐I expression in prostate stromal cells M Kawada, H Inoue, SI Ohba, T Masuda, I Momose, D Ikeda International journal of cancer 126 (4), 810-818, 2010 | 64 | 2010 |
Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression. M Shintani, A Okazaki, T Masuda, M Kawada, M Ishizuka, Y Doki, ... Anticancer research 22 (2A), 639-647, 2002 | 62 | 2002 |
Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata M Takemoto, Y Kawamura, M Hirohama, Y Yamaguchi, H Handa, ... The Journal of antibiotics 67 (4), 335-338, 2014 | 58 | 2014 |
Cytostatin, an inhibitor of cell adhesion to extracellular matrix, selectively inhibits protein phosphatase 2A M Kawada, M Amemiya, M Ishizuka, T Takeuchi Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1452 (2), 209-217, 1999 | 58 | 1999 |
Current targeted therapy for metastatic colorectal cancer T Ohishi, MK Kaneko, Y Yoshida, A Takashima, Y Kato, M Kawada International journal of molecular sciences 24 (2), 1702, 2023 | 52 | 2023 |
Specific inhibitors of protein phosphatase 2A inhibit tumor metastasis through augmentation of natural killer cells M Kawada, M Kawatsu, T Masuda, S Ohba, M Amemiya, T Kohama, ... International immunopharmacology 3 (2), 179-188, 2003 | 50 | 2003 |
A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma J Takei, MK Kaneko, T Ohishi, H Hosono, T Nakamura, M Yanaka, ... Oncology reports 44 (5), 1949-1960, 2020 | 49 | 2020 |
Rubratoxin A specifically and potently inhibits protein phosphatase 2A and suppresses cancer metastasis S Wada, I Usami, Y Umezawa, H Inoue, S Ohba, T Someno, M Kawada, ... Cancer science 101 (3), 743-750, 2010 | 48 | 2010 |
Identification of a small compound targeting PKM2-regulated signaling using 2D gel electrophoresis-based proteome-wide CETSA I Nagasawa, M Muroi, M Kawatani, T Ohishi, S Ohba, M Kawada, ... Cell Chemical Biology 27 (2), 186-196. e4, 2020 | 43 | 2020 |
Synthesis of intervenolin, an antitumor natural quinolone with unusual substituents H Abe, M Kawada, H Inoue, S Ohba, A Nomoto, T Watanabe, M Shibasaki Organic letters 15 (9), 2124-2127, 2013 | 42 | 2013 |
Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANC-1 cells under glucose-deprived conditions I Momose, S Ohba, D Tatsuda, M Kawada, T Masuda, G Tsujiuchi, ... Biochemical and biophysical research communications 392 (3), 460-466, 2010 | 42 | 2010 |
A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells M Kawada, Y Yoshimoto, K Minamiguchi, H Kumagai, T Someno, ... Anticancer research 24 (3A), 1561-1568, 2004 | 42 | 2004 |
Transforming growth factor-β1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I M Kawada, H Inoue, M Arakawa, D Ikeda Anticancer research 28 (2A), 721-730, 2008 | 41 | 2008 |
Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo Y Yoshimoto, M Kawada, D Ikeda, M Ishizuka International immunopharmacology 5 (2), 281-288, 2005 | 41 | 2005 |